§2200.7.2. Alzheimer's and other dementia diseases training; rulemaking
A. The Louisiana Department of Health shall, in its existing public health programs
and services, educate healthcare providers on all of the following:
(1) The importance of effective care planning, including treatment options, support
and services, long-term care options, advance directives, and care at every stage of
Alzheimer's disease and other dementia diseases to include appropriate counseling.
(2) The use of validated cognitive assessment tools.
B. The office of public health within the Louisiana Department of Health shall
include provisions in its public health outreach programs that, at a minimum, address the
following:
(1) Increasing the awareness of Alzheimer's disease and other dementia diseases
including any link to chronic disease, such as vascular risk factors.
(2) Advising the public of the value of early detection of Alzheimer's disease and
other dementia diseases along with information on the early signs of the diseases.
(3) Educating the public on the importance of identifying and reporting signs of
Alzheimer's disease and other dementia diseases to healthcare providers for timely diagnosis.
(4) Increasing the data and surveillance applicable to Alzheimer's disease and other
dementia diseases and encouraging additional data analysis and accurate reporting on death
certificates.
C. The Louisiana Department of Health shall consult with the Louisiana chapter of
the Alzheimer's Association and other experts, advocates, or associations to facilitate the
distribution of educational materials that address Alzheimer's disease and other dementia
diseases.
D. The Louisiana Department of Health may promulgate rules and regulations in
accordance with the Administrative Procedure Act as are necessary to implement this
Subpart. The rules and regulations may include but not be limited to the type of cognitive
assessment tools available to healthcare providers. The department shall consult with and
seek input from the Louisiana chapter of the Alzheimer's Association and other experts,
advocates, or associations in the promulgation of the rules and regulations.
Acts 2021, No. 73, §1; Acts 2024, No. 376, §1.